[
  {
    "title": "VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations",
    "link": "https://finance.yahoo.com/news/vrtx-stock-down-q1-sales-112600638.html"
  },
  {
    "title": "Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip",
    "link": "https://finance.yahoo.com/news/why-vertex-pharmaceuticals-stock-screaming-084900253.html"
  },
  {
    "title": "1 S&P 500 Stock with Impressive Fundamentals and 2 to Ignore",
    "link": "https://finance.yahoo.com/news/1-p-500-stock-impressive-043149540.html"
  },
  {
    "title": "Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash",
    "link": "https://finance.yahoo.com/m/bb8a4622-9ea5-346d-9b42-b1d653307b4a/stocks-to-watch-recap-.html"
  },
  {
    "title": "S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop",
    "link": "https://finance.yahoo.com/news/p-500-gains-losses-today-204959480.html"
  },
  {
    "title": "Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks",
    "link": "https://finance.yahoo.com/m/367a34c6-91d6-3c10-b421-d5df0dc637e1/vertex-pharmaceuticals.html"
  },
  {
    "title": "Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?",
    "link": "https://finance.yahoo.com/news/why-did-vertex-pharmaceuticals-stock-202844445.html"
  },
  {
    "title": "Stock Market Today: Dow Jones, S&P 500 Fall Again; Gold Stocks Rally While Palantir Tumbles (Live Coverage)",
    "link": "https://finance.yahoo.com/m/2a52960f-5f7d-319d-8850-8de18c4df34b/stock-market-today-dow.html"
  },
  {
    "title": "Uber-Pony AI partnership, EVgo boost, Vertex earnings miss",
    "link": "https://finance.yahoo.com/video/uber-pony-ai-partnership-evgo-180833725.html"
  },
  {
    "title": "Vertex Pharmaceuticals (NasdaqGS:VRTX) Raises Guidance Despite Intangible Asset Impairment Charge",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-nasdaqgs-vrtx-raises-172929502.html"
  },
  {
    "title": "Vertex Pharmaceuticals Stock Is Tumbling After Earnings. Here’s Why.",
    "link": "https://finance.yahoo.com/m/f6666914-539d-3880-b887-5346309e9b8d/vertex-pharmaceuticals-stock.html"
  },
  {
    "title": "VRTX's Q1 Earnings Lag Estimates, 2025 Revenue View Tightened",
    "link": "https://finance.yahoo.com/news/vrtxs-q1-earnings-lag-estimates-155900293.html"
  },
  {
    "title": "Top Stock Movers Now: Vertex, DoorDash, Constellation Energy, and More",
    "link": "https://finance.yahoo.com/news/top-stock-movers-now-vertex-155816749.html"
  },
  {
    "title": "Vertex Pharmaceuticals Stock Sinks as Costs Soar",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-stock-sinks-costs-144825025.html"
  },
  {
    "title": "Why Vertex Pharmaceuticals Stock Is Sinking Today",
    "link": "https://finance.yahoo.com/news/why-vertex-pharmaceuticals-stock-sinking-143608257.html"
  },
  {
    "title": "Rising Costs Weigh on Vertex Q1 Earnings",
    "link": "https://finance.yahoo.com/news/rising-costs-weigh-vertex-q1-131146806.html"
  },
  {
    "title": "Q1 2025 Vertex Pharmaceuticals Inc Earnings Call",
    "link": "https://finance.yahoo.com/news/q1-2025-vertex-pharmaceuticals-inc-112929681.html"
  },
  {
    "title": "Vertex Pharmaceuticals Inc (VRTX) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Challenges",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-inc-vrtx-q1-070616353.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Misses Q1 Earnings and Revenue Estimates",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-misses-q1-211507546.html"
  },
  {
    "title": "Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Sales Below Analyst Estimates In Q1 Earnings",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-nasdaq-vrtx-reports-204658078.html"
  },
  {
    "title": "Vertex misses quarterly results on weaker-than-expected sales for cystic fibrosis drug",
    "link": "https://finance.yahoo.com/news/vertex-misses-quarterly-results-weaker-201759971.html"
  },
  {
    "title": "Vertex: Q1 Earnings Snapshot",
    "link": "https://finance.yahoo.com/news/vertex-q1-earnings-snapshot-200929787.html"
  },
  {
    "title": "Vertex Reports First Quarter 2025 Financial Results",
    "link": "https://finance.yahoo.com/news/vertex-reports-first-quarter-2025-200100412.html"
  },
  {
    "title": "Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now",
    "link": "https://finance.yahoo.com/news/stock-market-selloff-4-no-110000417.html"
  },
  {
    "title": "5 Growth Stocks to Buy in May and Go Away",
    "link": "https://finance.yahoo.com/news/5-growth-stocks-buy-may-084200445.html"
  },
  {
    "title": "Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow",
    "link": "https://finance.yahoo.com/news/earnings-watch-vertex-pharmaceuticals-vrtx-070405475.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-outperforms-broader-215017195.html"
  },
  {
    "title": "What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings",
    "link": "https://finance.yahoo.com/news/analyst-projections-key-metrics-reveal-131520656.html"
  },
  {
    "title": "Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for",
    "link": "https://finance.yahoo.com/news/analysts-estimate-entrada-therapeutics-inc-140132583.html"
  },
  {
    "title": "Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?",
    "link": "https://finance.yahoo.com/news/vertex-gears-report-q1-earnings-115100475.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-expected-beat-140040795.html"
  },
  {
    "title": "My 5 Top Stocks to Buy Right Now in This Highly Volatile Market",
    "link": "https://finance.yahoo.com/news/5-top-stocks-buy-now-084800780.html"
  },
  {
    "title": "Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks",
    "link": "https://finance.yahoo.com/m/54caf1db-e1d5-3dfe-b9ff-638d5851edfa/wall-street%E2%80%99s-new-tariff-safe.html"
  },
  {
    "title": "CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?",
    "link": "https://finance.yahoo.com/news/crispr-therapeutics-report-q1-earnings-155900797.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-advances-underperforms-215014115.html"
  },
  {
    "title": "Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds",
    "link": "https://finance.yahoo.com/news/top-20-biopharmas-market-cap-174924492.html"
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-trending-130010040.html"
  },
  {
    "title": "Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday",
    "link": "https://finance.yahoo.com/news/why-vertex-pharmaceuticals-healthy-stock-213705596.html"
  },
  {
    "title": "3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold",
    "link": "https://finance.yahoo.com/news/3-relatively-safe-healthcare-growth-135300768.html"
  },
  {
    "title": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
    "link": "https://finance.yahoo.com/news/why-investors-advantage-2-medical-130009008.html"
  },
  {
    "title": "Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right",
    "link": "https://finance.yahoo.com/news/fed-chairman-jerome-powell-warns-084700435.html"
  },
  {
    "title": "Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-nasdaqgs-vrtx-faces-171554670.html"
  },
  {
    "title": "Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next",
    "link": "https://finance.yahoo.com/news/dont-try-time-market-2-103000356.html"
  },
  {
    "title": "Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce",
    "link": "https://finance.yahoo.com/news/stock-market-whiplash-3-growth-084500504.html"
  },
  {
    "title": "April 2025's Stocks That May Be Priced Below Their Estimated Value",
    "link": "https://finance.yahoo.com/news/april-2025s-stocks-may-priced-173754256.html"
  },
  {
    "title": "Exploring 3 High Growth Tech Stocks In The US Market",
    "link": "https://finance.yahoo.com/news/exploring-3-high-growth-tech-113810608.html"
  },
  {
    "title": "Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades",
    "link": "https://finance.yahoo.com/news/nasdaq-market-whiplash-3-stocks-084800304.html"
  },
  {
    "title": "Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis",
    "link": "https://finance.yahoo.com/news/vertex-researcher-paul-negulescu-ph-093000494.html"
  },
  {
    "title": "Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?",
    "link": "https://finance.yahoo.com/news/could-crispr-therapeutics-become-next-074500634.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-stock-moves-215013109.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-surged-increased-125550036.html"
  },
  {
    "title": "We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.",
    "link": "https://finance.yahoo.com/news/were-answer-warren-buffetts-pointed-075200819.html"
  },
  {
    "title": "5 Top Growth Stocks to Buy in the Stock Market Sell-Off",
    "link": "https://finance.yahoo.com/news/5-top-growth-stocks-buy-140000326.html"
  },
  {
    "title": "Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know",
    "link": "https://finance.yahoo.com/news/investors-heavily-search-vertex-pharmaceuticals-130009640.html"
  },
  {
    "title": "An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued",
    "link": "https://finance.yahoo.com/news/intrinsic-calculation-vertex-pharmaceuticals-incorporated-110014751.html"
  },
  {
    "title": "Jim Cramer Calls Vertex Pharmaceuticals Incorporated (VRTX) “Terrific” With “Revolutionary Pain Drug”",
    "link": "https://finance.yahoo.com/news/jim-cramer-calls-vertex-pharmaceuticals-182451797.html"
  },
  {
    "title": "Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Long Term Growth Stock to Buy According to Billionaires?",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-best-180937352.html"
  },
  {
    "title": "Is Vertex Pharmaceuticals Stock a Buy?",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-stock-buy-134500792.html"
  },
  {
    "title": "VRTX Secures Nod for Expanded Use of CF Drug Kaftrio in Europe",
    "link": "https://finance.yahoo.com/news/vrtx-secures-nod-expanded-cf-105500149.html"
  },
  {
    "title": "Vertex to Announce First Quarter 2025 Financial Results on May 5th",
    "link": "https://finance.yahoo.com/news/vertex-announce-first-quarter-2025-200500618.html"
  },
  {
    "title": "European Commission Approves Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis",
    "link": "https://finance.yahoo.com/news/european-commission-approves-expanded-label-160000775.html"
  },
  {
    "title": "2 Stocks to Buy if You're Worried About a Recession",
    "link": "https://finance.yahoo.com/news/2-stocks-buy-youre-worried-092400242.html"
  },
  {
    "title": "Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4",
    "link": "https://finance.yahoo.com/news/spotting-winners-united-therapeutics-nasdaq-091131284.html"
  },
  {
    "title": "Worried About Trump's New Tariffs? These 3 U.S. Companies Are Set to Weather the Storm",
    "link": "https://finance.yahoo.com/news/worried-trumps-tariffs-3-u-094500912.html"
  },
  {
    "title": "Corporate CFOs Think a Recession Is Coming. Here Are 3 Stocks to Own If They're Right.",
    "link": "https://finance.yahoo.com/news/corporate-cfos-think-recession-coming-084200201.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-increases-despite-215010720.html"
  },
  {
    "title": "Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks",
    "link": "https://finance.yahoo.com/news/q4-earnings-outperformers-amgen-nasdaq-090834226.html"
  },
  {
    "title": "Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-best-164256812.html"
  },
  {
    "title": "Biotech stocks slide as Marks resignation seen being negative for sector",
    "link": "https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html"
  },
  {
    "title": "VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates",
    "link": "https://finance.yahoo.com/news/vrtx-provides-mixed-updates-type-145500721.html"
  },
  {
    "title": "These biotech names aren't facing 'huge concern' from tariffs",
    "link": "https://finance.yahoo.com/video/biotech-names-arent-facing-huge-113025462.html"
  },
  {
    "title": "Intellia Focuses on Pipeline Development Amid Stiff Competition",
    "link": "https://finance.yahoo.com/news/intellia-focuses-pipeline-development-amid-141000427.html"
  },
  {
    "title": "Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”",
    "link": "https://finance.yahoo.com/news/jim-cramer-vertex-pharmaceuticals-vrtx-133352020.html"
  },
  {
    "title": "Vertex halts development of diabetes cell therapy after trial failure",
    "link": "https://finance.yahoo.com/news/vertex-halts-development-diabetes-cell-113537231.html"
  },
  {
    "title": "Vertex Pharmaceuticals (NasdaqGS:VRTX) Advances Diabetes Portfolio Despite 2% Decline in Share Price",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-nasdaqgs-vrtx-advances-171434311.html"
  },
  {
    "title": "Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-most-expensive-230659098.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-stock-moves-215010851.html"
  },
  {
    "title": "Vertex Announces Program Updates for Type 1 Diabetes Portfolio",
    "link": "https://finance.yahoo.com/news/vertex-announces-program-updates-type-200500796.html"
  },
  {
    "title": "Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession",
    "link": "https://finance.yahoo.com/news/rattled-stock-market-sell-off-103000828.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-advances-while-220016824.html"
  },
  {
    "title": "Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.",
    "link": "https://finance.yahoo.com/m/a0a5b586-6548-32ba-a471-4b92d7cd09e4/trump-weighs-tariffs-on.html"
  },
  {
    "title": "Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock",
    "link": "https://finance.yahoo.com/news/know-beyond-why-vertex-pharmaceuticals-130009445.html"
  },
  {
    "title": "Jim Cramer on Vertex (VRTX): “A Revolutionary Anti-Pain Drug”",
    "link": "https://finance.yahoo.com/news/jim-cramer-vertex-vrtx-revolutionary-144012884.html"
  },
  {
    "title": "2 Beaten-Down Stocks to Buy on the Dip",
    "link": "https://finance.yahoo.com/news/2-beaten-down-stocks-buy-200400114.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-stock-falls-215017385.html"
  },
  {
    "title": "Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue?",
    "link": "https://finance.yahoo.com/news/amicus-therapeutics-fold-0-1-153030627.html"
  },
  {
    "title": "As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point",
    "link": "https://finance.yahoo.com/m/9572d0e0-19cf-3498-a60c-ecc61fb67c5d/as-the-biotech-sector-remains.html"
  },
  {
    "title": "Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks",
    "link": "https://finance.yahoo.com/news/q4-rundown-biogen-nasdaq-biib-091250195.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Rises But Trails Market: What Investors Should Know",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-rises-trails-220019619.html"
  },
  {
    "title": "Is Vertex Pharmaceuticals (VRTX) the Best Diabetes Stock to Buy According to Billionaires?",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-best-diabetes-141655970.html"
  },
  {
    "title": "Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next",
    "link": "https://finance.yahoo.com/news/nasdaq-sell-off-2-brilliant-140200066.html"
  },
  {
    "title": "CRISPR Therapeutics AG (CRSP): A Bull Case Theory",
    "link": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-bull-134147858.html"
  },
  {
    "title": "A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack",
    "link": "https://finance.yahoo.com/news/look-back-therapeutics-stocks-q4-090511094.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX): One of the Best Biotech Stocks to Buy According to Billionaires",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-one-best-092615738.html"
  },
  {
    "title": "Is Vertex Pharmaceuticals (VRTX) Among the Best High Growth Stocks?",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-among-best-065802946.html"
  },
  {
    "title": "Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?",
    "link": "https://finance.yahoo.com/news/vertex-25-ytd-buy-sell-144700220.html"
  },
  {
    "title": "3 Unstoppable Stocks You Can Buy Now Without Any Hesitation",
    "link": "https://finance.yahoo.com/news/3-unstoppable-stocks-buy-now-104700216.html"
  },
  {
    "title": "Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report?",
    "link": "https://finance.yahoo.com/news/why-alkermes-alks-down-6-153034625.html"
  },
  {
    "title": "3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now",
    "link": "https://finance.yahoo.com/news/3-no-brainer-healthcare-stocks-095100770.html"
  },
  {
    "title": "Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today",
    "link": "https://finance.yahoo.com/news/why-market-dipped-vertex-pharmaceuticals-215016942.html"
  },
  {
    "title": "GILD vs. VRTX: Which Stock Is the Better Value Option?",
    "link": "https://finance.yahoo.com/news/gild-vs-vrtx-stock-better-154008867.html"
  },
  {
    "title": "Why Vertex Pharmaceuticals Incorporated (VRTX) is the Best Pharma Stock to Buy According to Hedge Funds",
    "link": "https://finance.yahoo.com/news/why-vertex-pharmaceuticals-incorporated-vrtx-182931508.html"
  },
  {
    "title": "Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?",
    "link": "https://finance.yahoo.com/news/why-vertex-vrtx-7-3-153014850.html"
  },
  {
    "title": "Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?",
    "link": "https://finance.yahoo.com/news/consider-adding-vertex-pharmaceuticals-incorporated-125756632.html"
  },
  {
    "title": "Company News for Mar 11, 2025",
    "link": "https://finance.yahoo.com/news/company-news-mar-11-2025-132200201.html"
  },
  {
    "title": "Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever",
    "link": "https://finance.yahoo.com/news/nasdaq-correction-2-smartest-stocks-093100570.html"
  },
  {
    "title": "3 Reasons to Avoid VRTX and 1 Stock to Buy Instead",
    "link": "https://finance.yahoo.com/news/3-reasons-avoid-vrtx-1-090517097.html"
  },
  {
    "title": "Where Will Vertex Pharmaceuticals Be in 10 Years?",
    "link": "https://finance.yahoo.com/news/where-vertex-pharmaceuticals-10-years-082500804.html"
  },
  {
    "title": "If I Could Buy Only 1 Growth Stock, This Would Be It",
    "link": "https://finance.yahoo.com/news/could-buy-only-1-growth-123000903.html"
  },
  {
    "title": "3 Magnificent Growth Stocks to Buy in March",
    "link": "https://finance.yahoo.com/news/3-magnificent-growth-stocks-buy-154100845.html"
  },
  {
    "title": "Vertex Pharmaceuticals (NasdaqGS:VRTX) Gains UK Approval For New Cystic Fibrosis Treatment",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-nasdaqgs-vrtx-gains-172124136.html"
  },
  {
    "title": "Update: Vertex Pharmaceuticals Says Journavx Non-Opioid Pain Killer Added to Optum Formulary",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-says-journavx-non-165405587.html"
  },
  {
    "title": "Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis",
    "link": "https://finance.yahoo.com/news/vertex-announces-uk-mhra-approval-150200748.html"
  },
  {
    "title": "Vertex Pharmaceuticals Says Journavx Non-Opioid Pain Killer Added to Optum Formulary",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-says-journavx-non-185119278.html"
  },
  {
    "title": "Vertex Pharmaceuticals Leads 3 Value Stocks Offering Estimated Intrinsic Value",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-leads-3-value-110757532.html"
  },
  {
    "title": "5 Top Stocks to Buy in March",
    "link": "https://finance.yahoo.com/news/5-top-stocks-buy-march-111500122.html"
  },
  {
    "title": "Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations",
    "link": "https://finance.yahoo.com/news/vertex-receives-chmp-positive-opinion-122200046.html"
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-attracting-140013390.html"
  },
  {
    "title": "Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market",
    "link": "https://finance.yahoo.com/news/sionna-therapeutics-ipo-strategic-shift-105651362.html"
  },
  {
    "title": "Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment",
    "link": "https://finance.yahoo.com/news/vertexs-fda-win-billion-dollar-215010625.html"
  },
  {
    "title": "High Growth Tech Stocks To Watch In February 2025",
    "link": "https://finance.yahoo.com/news/high-growth-tech-stocks-watch-140215517.html"
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX): Among Renaissance Technologies Portfolio’s Top Stock Picks",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-among-181731673.html"
  },
  {
    "title": "3 Magnificent Growth Stocks to Buy Right Now",
    "link": "https://finance.yahoo.com/news/3-magnificent-growth-stocks-buy-104700329.html"
  },
  {
    "title": "GILD or VRTX: Which Is the Better Value Stock Right Now?",
    "link": "https://finance.yahoo.com/news/gild-vrtx-better-value-stock-164015316.html"
  },
  {
    "title": "Vertex to Participate in Upcoming March Investor Conferences",
    "link": "https://finance.yahoo.com/news/vertex-participate-upcoming-march-investor-210500506.html"
  },
  {
    "title": "3 Stocks That Could Trounce the Market in 2025",
    "link": "https://finance.yahoo.com/news/3-stocks-could-trounce-market-093200083.html"
  },
  {
    "title": "2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025",
    "link": "https://finance.yahoo.com/news/2-healthcare-stocks-tumbled-2024-134500875.html"
  },
  {
    "title": "CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99",
    "link": "https://finance.yahoo.com/news/crispr-crsp-upgraded-outperform-evercore-172046570.html"
  },
  {
    "title": "The Ultimate Healthcare Stock to Buy With $500 Right Now",
    "link": "https://finance.yahoo.com/news/ultimate-healthcare-stock-buy-500-104700086.html"
  },
  {
    "title": "Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-gets-huge-fda-093500138.html"
  },
  {
    "title": "Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-price-target-raised-144150629.html"
  },
  {
    "title": "Vertex Pharmaceuticals price target raised to $520 from $460 at Truist",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-price-target-raised-144101458.html"
  },
  {
    "title": "CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates",
    "link": "https://finance.yahoo.com/news/crispr-therapeutics-q4-earnings-revenues-143400664.html"
  },
  {
    "title": "Vertex Posts 'Another Impressive Quarterly Revenue Beat.' But The Future Remains Uncertain.",
    "link": "https://finance.yahoo.com/m/0bb17aef-f19d-38e5-8737-6f2588669718/vertex-posts-another.html"
  },
  {
    "title": "VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales",
    "link": "https://finance.yahoo.com/news/vrtxs-q4-earnings-miss-mark-160000598.html"
  },
  {
    "title": "Vertex: Strong Sales, Stronger Pipeline",
    "link": "https://finance.yahoo.com/news/vertex-strong-sales-stronger-pipeline-141500792.html"
  },
  {
    "title": "Q4 2024 Vertex Pharmaceuticals Inc Earnings Call",
    "link": "https://finance.yahoo.com/news/q4-2024-vertex-pharmaceuticals-inc-141034025.html"
  },
  {
    "title": "Vertex Pharmaceuticals Inc (VRTX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-inc-vrtx-q4-070653978.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call Transcript",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-q4-2024-014512776.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Misses Q4 Earnings Estimates",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-misses-q4-221004701.html"
  },
  {
    "title": "Vertex Pharmaceuticals' Revenue Forecast Tops Expectations",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-revenue-forecast-tops-213026039.html"
  },
  {
    "title": "Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 Sales Top Estimates",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-nasdaq-vrtx-q4-211734678.html"
  },
  {
    "title": "Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand",
    "link": "https://finance.yahoo.com/news/vertex-forecasts-upbeat-2025-revenue-211347135.html"
  },
  {
    "title": "Vertex: Q4 Earnings Snapshot",
    "link": "https://finance.yahoo.com/news/vertex-q4-earnings-snapshot-211140982.html"
  },
  {
    "title": "Vertex Reports Fourth Quarter and Full Year 2024 Financial Results",
    "link": "https://finance.yahoo.com/news/vertex-reports-fourth-quarter-full-210100360.html"
  },
  {
    "title": "Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?",
    "link": "https://finance.yahoo.com/news/5-biotech-bigwig-stocks-surpass-184200903.html"
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Intrinsic Value Is Potentially 50% Above Its Share Price",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporateds-nasdaq-vrtx-140019817.html"
  },
  {
    "title": "2 Biotech Stocks to Buy Hand Over Fist in February",
    "link": "https://finance.yahoo.com/news/2-biotech-stocks-buy-hand-161500411.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-q4-earnings-130414686.html"
  },
  {
    "title": "What To Expect in the Markets This Week",
    "link": "https://finance.yahoo.com/news/expect-markets-week-100000871.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-amgen-102300630.html"
  },
  {
    "title": "Is VRTX a Portfolio Must Have After Two FDA Nods Ahead of Q4 Earnings?",
    "link": "https://finance.yahoo.com/news/vrtx-portfolio-must-two-fda-145400940.html"
  },
  {
    "title": "Unlocking Q4 Potential of Vertex (VRTX): Exploring Wall Street Estimates for Key Metrics",
    "link": "https://finance.yahoo.com/news/unlocking-q4-potential-vertex-vrtx-141525779.html"
  },
  {
    "title": "Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release",
    "link": "https://finance.yahoo.com/news/gilead-sciences-gild-expected-beat-150039757.html"
  },
  {
    "title": "Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?",
    "link": "https://finance.yahoo.com/news/vertex-pharma-just-scored-major-121000706.html"
  },
  {
    "title": "US Stocks Estimated To Be Trading Below Intrinsic Value In February 2025",
    "link": "https://finance.yahoo.com/news/us-stocks-estimated-trading-below-100220882.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-ascends-while-225022711.html"
  },
  {
    "title": "3 Magnificent Stocks to Buy and Hold Forever",
    "link": "https://finance.yahoo.com/news/3-magnificent-stocks-buy-hold-143000674.html"
  },
  {
    "title": "Vertex (VRTX) Surges 5.3%: Is This an Indication of Further Gains?",
    "link": "https://finance.yahoo.com/news/vertex-vrtx-surges-5-3-140300083.html"
  },
  {
    "title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "link": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-140012367.html"
  },
  {
    "title": "Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?",
    "link": "https://finance.yahoo.com/news/5-biotech-stocks-set-beat-124300578.html"
  },
  {
    "title": "Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-just-won-huge-130600405.html"
  },
  {
    "title": "Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-buy-now-fda-103500888.html"
  },
  {
    "title": "Vertex Pharmaceuticals price target raised to $433 from $430 at Scotiabank",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-price-target-raised-140521184.html"
  },
  {
    "title": "How Painkillers Could Be Vertex Pharmaceuticals' Next $10 Billion Chapter",
    "link": "https://finance.yahoo.com/m/9c5d533e-0af9-36eb-93e1-058193421324/how-painkillers-could-be.html"
  },
  {
    "title": "AbbVie, Vertex's Journavx, Exxon and Chevron: Market Minute",
    "link": "https://finance.yahoo.com/video/abbvie-vertexs-journavx-exxon-chevron-171656727.html"
  },
  {
    "title": "Vertex stock jumps on FDA approval of new non-opioid painkiller",
    "link": "https://finance.yahoo.com/video/vertex-stock-jumps-fda-approval-170833139.html"
  },
  {
    "title": "No Major Catalyst, Wells Fargo Downgraded Vertex",
    "link": "https://finance.yahoo.com/news/no-major-catalyst-wells-fargo-155955683.html"
  },
  {
    "title": "VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up",
    "link": "https://finance.yahoo.com/news/vrtx-gets-fda-nod-non-155600022.html"
  },
  {
    "title": "The FDA approved a new non-opioid painkiller. Its maker's stock is rising",
    "link": "https://finance.yahoo.com/news/fda-approved-non-opioid-painkiller-134125028.html"
  },
  {
    "title": "Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-stock-jumps-non-145652959.html"
  },
  {
    "title": "Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller",
    "link": "https://finance.yahoo.com/m/c4c28a90-b5c8-3776-8cef-8625c0e02017/vertex-pharmaceuticals-jumps.html"
  },
  {
    "title": "NHS England to offer Casgevy for sickle cell disease patients",
    "link": "https://finance.yahoo.com/news/nhs-england-offer-casgevy-sickle-124714217.html"
  },
  {
    "title": "FDA approves Vertex’s acute pain treatment Journavx",
    "link": "https://finance.yahoo.com/news/fda-approves-vertex-acute-pain-093613620.html"
  },
  {
    "title": "Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England",
    "link": "https://finance.yahoo.com/news/vertex-announces-casgevy-reimbursement-agreement-070000788.html"
  },
  {
    "title": "Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain",
    "link": "https://finance.yahoo.com/news/vertex-announces-fda-approval-journavx-232500232.html"
  },
  {
    "title": "Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’",
    "link": "https://finance.yahoo.com/news/jim-cramer-vertex-pharmaceuticals-incorporated-195021879.html"
  },
  {
    "title": "Vertex Pharmaceuticals (NASDAQ:VRTX) lifts 3.2% this week, taking five-year gains to 83%",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-nasdaq-vrtx-lifts-130028354.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-stock-slides-230023244.html"
  },
  {
    "title": "Earnings Preview: Vertex Pharmaceuticals (VRTX) Q4 Earnings Expected to Decline",
    "link": "https://finance.yahoo.com/news/earnings-preview-vertex-pharmaceuticals-vrtx-150019012.html"
  },
  {
    "title": "Vertex to Announce Fourth Quarter and Full Year 2024 Financial Results on February 10",
    "link": "https://finance.yahoo.com/news/vertex-announce-fourth-quarter-full-123000567.html"
  },
  {
    "title": "Is Vertex Pharmaceuticals Stock a Buy in 2025?",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-stock-buy-2025-113000571.html"
  },
  {
    "title": "Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.",
    "link": "https://finance.yahoo.com/news/got-5-000-2-top-161500609.html"
  },
  {
    "title": "Exploring Three High Growth Tech Stocks In The United States",
    "link": "https://finance.yahoo.com/news/exploring-three-high-growth-tech-140306827.html"
  },
  {
    "title": "2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher",
    "link": "https://finance.yahoo.com/news/2-healthcare-stocks-buy-now-091500992.html"
  },
  {
    "title": "Vertex Down 13% in 6 Months: Buy, Sell or Hold the Stock?",
    "link": "https://finance.yahoo.com/news/vertex-down-13-6-months-200000936.html"
  },
  {
    "title": "Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever",
    "link": "https://finance.yahoo.com/news/got-1-500-3-healthcare-232212241.html"
  },
  {
    "title": "3 Unstoppable Stocks to Buy in 2025",
    "link": "https://finance.yahoo.com/news/3-unstoppable-stocks-buy-2025-114000017.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-dips-more-230022828.html"
  },
  {
    "title": "Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?",
    "link": "https://finance.yahoo.com/news/buy-vertex-pharmaceuticals-stock-hand-104900293.html"
  },
  {
    "title": "Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-sets-sight-expanding-194709082.html"
  },
  {
    "title": "Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings",
    "link": "https://finance.yahoo.com/news/vertex-provides-pipeline-business-updates-220100776.html"
  },
  {
    "title": "Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement",
    "link": "https://finance.yahoo.com/news/zai-lab-vertex-pharmaceuticals-announce-124121180.html"
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Stock Moves -0.62%: What You Should Know",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-stock-moves-225022133.html"
  },
  {
    "title": "INCY vs. VRTX: Which Stock Is the Better Value Option?",
    "link": "https://finance.yahoo.com/news/incy-vs-vrtx-stock-better-164008695.html"
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX) Slid due to Setbacks In Clinical Trials",
    "link": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-slid-134213096.html"
  },
  {
    "title": "Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore",
    "link": "https://finance.yahoo.com/news/zai-lab-vertex-announce-strategic-123000159.html"
  },
  {
    "title": "Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore",
    "link": "https://finance.yahoo.com/news/vertex-zai-lab-announce-strategic-123000682.html"
  },
  {
    "title": "An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 42% Undervalued",
    "link": "https://finance.yahoo.com/news/intrinsic-calculation-vertex-pharmaceuticals-incorporated-110024286.html"
  },
  {
    "title": "Vertex and Orna sign partnership to improve efficiencies of gene therapies",
    "link": "https://finance.yahoo.com/news/vertex-orna-sign-partnership-improve-122103291.html"
  }
]